Abstract
These guidelines on the management of basal cell carcinoma have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.
Publication types
-
Guideline
-
Practice Guideline
MeSH terms
-
Antimetabolites, Antineoplastic / therapeutic use
-
Carcinoma, Basal Cell / diagnosis
-
Carcinoma, Basal Cell / surgery*
-
Carcinoma, Basal Cell / therapy
-
Fluorouracil / therapeutic use
-
Humans
-
Interferon Type I / therapeutic use
-
Palliative Care
-
Phototherapy
-
Recombinant Proteins
-
Skin Neoplasms / diagnosis
-
Skin Neoplasms / surgery*
-
Skin Neoplasms / therapy
Substances
-
Antimetabolites, Antineoplastic
-
Interferon Type I
-
Recombinant Proteins
-
Fluorouracil